Skip to content

Prophylactic Oxytocin Before Versus After Placental Delivery to Reduce Blood Loss in Vaginal Delivery

Prophylactic Oxytocin Before Versus After Placental Delivery to Reduce Blood Loss in Vaginal Delivery

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03006380
Enrollment
400
Registered
2016-12-30
Start date
2016-08-31
Completion date
2017-09-30
Last updated
2017-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Hemorrhage

Brief summary

Randomized controlled study to assess the efficacy and safety of the timing of administration of prophylactic oxytocin via intramuscular route (before compared to after placental delivery) on blood loss in vaginal delivery.

Detailed description

400 patients will be recruited for the study,Informed consent will be obtained from all patients following the research criteria once they are admitted in active labor, but they will be enrolled and randomized only when they reach the second stage of labor (fully dilated cervix) as it will be difficult in this stage to counsel patients. The recruited patients will be subjected to the following: * History taking: with particular emphasis on past medical history (especially for bleeding tendency), past obstetric history. * Checking vital signs, General and abdominal examination. * laboratory investigations: complete blood count (CBC) * Findings of the initial obstetric evaluation follow up, labor duration and the need for oxytocin augmentation will be recorded through a partogram. * All deliveries will be attended by a senior resident in the hospital. * Included patients will receive the medication according to randomization tables. * After allocation, patients will be excluded only if they required cesarean section, instrumental delivery or had multiple or deep vaginal tears that compromise estimation of uterine blood loss. * All patients will undergo gentle traction to the umbilical cord while providing counter traction against the uterine fundus after signs of placental separation; appearance of bleeding, elongation of the cord. * All patients will undergo cord clamping and cutting within 30 seconds of delivery. * All patients will undergo uterine massage for 30 seconds after placental delivery. * Vital signs (blood pressure and pulse) will be checked 15 minutes, 1 hour and 6 hours after placental delivery. * CBC will be collected 6 hours after delivery.

Interventions

DRUGoxytocin

Ecbolic used to reduce blood loss

Sponsors

Ain Shams Maternity Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

1. Multiparous women (had previous one, up to four deliveries) 2. Term pregnancy (37 completed weeks at least). 3. Singleton viable cephalic pregnancy. 4. Vaginal delivery.

Exclusion criteria

1. Primigravida.(first pregnancy) 2. Grand multiparous. (had previous 5 or more deliveries) 3. Maternal illness (involving pregnancy induced condition; PIH,GDM or chronic medical condition; hypertension, cardiac , renal problems) 4. Previous cesarean section, uterine surgery. 5. Patients with bleeding tendency. 6. Previous history of Ante-partum hemorrhage. 7. Previous history of postpartum hemorrhage. 8. Abnormal site of the placenta (detected by ultrasound) 9. Macrosomic baby (EFW more than 4000 gm estimated clinically or by ultrasound) 10. polyhydramnios.(detected by ultrasound) 11. Multiple gestation. 12. Chorioamnionitis. 13. Suspected fetal problem(anomaly, distress) 14. Instrumental delivery. 15. Multiple or deep vaginal tears that compromise the estimation of uterine blood loss. 16. Cesarean delivery

Design outcomes

Primary

MeasureTime frame
blood loss in vaginal deliveryblood loss in the third stage of labor (Up to 60 min after delivery of the baby)

Secondary

MeasureTime frame
surgical intervention to stop the bleedingwithin 24 hours after delivery
primary postpartum hemorrhagewithin 24 hours after delivery
changes in hemoglobin and hematocritbefore delivery and after 6 hours
retained placentamore than 30 minutes after delivery
secondary postpartum hemorrhageafter 24 hours and before 6 weeks from delivery
manual removal of the placentaif not separated after 30 minutes from delivery
blood pressureto be measured before delivery after 15 minutes,1 hour,6 hours
maternal painduring third stage of labor
maternal nausea and vomitingduring 3rd stage of labor
length of 3rd stage of laborUp to 60 min from delivery of baby till delivery of placenta

Countries

Egypt

Contacts

Primary ContactReham Marie, MRCOG
rehamfarghal84@gmail.com+201212977339

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026